Cardiovascular and renal protective effects of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation

<h4>Aim</h4> Data on the use of non-vitamin K antagonist oral anticoagulants (NOACs) in relation to the risk of cardiovascular (CV) disease and renal protection among patients with atrial fibrillation (AF), are relatively sparse. We aimed to compare the effectiveness and safety of NOACs...

Full description

Bibliographic Details
Published in:	PLoS ONE
Main Authors:	Seong Huan Choi, Mina Kim, Hoseob Kim, Dae-Hyeok Kim, Yong-Soo Baek
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2022-01-01
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560050/?tool=EBI

Similar Items

Risk of Ischemic Bowel Disease in Patients With Atrial Fibrillation Receiving Warfarin or Non-vitamin K Antagonist Oral Anticoagulants
by: Jo-Nan Liao, et al.
Published: (2022-07-01)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-11-01)

Renal function decline in Asian patients with atrial fibrillation with warfarin and non‐vitamin K antagonist oral anticoagulants: A report from the COOL‐AF registry
by: Rungroj Krittayaphong, et al.
Published: (2025-04-01)

Real‐life experience with non‐vitamin K antagonist oral anticoagulants versus warfarin in patients undergoing elective cardioversion of atrial fibrillation
by: Saga Itäinen‐Strömberg, et al.
Published: (2020-09-01)

Cost-effectiveness of Direct Oral Anticoagulant vs. Warfarin Among Atrial Fibrillation Patients With Intermediate Stroke Risk
by: Ju Hee Choi, et al.
Published: (2022-04-01)

Evaluation of the anticoagulant effect of vitamin K antagonists in patients with non-valvular atrial fibrilation
by: Stanojković Zoran, et al.
Published: (2020-01-01)

Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation
by: Anetta Undas, et al.
Published: (2019-12-01)

Kidney Function and the Use of Vitamin K Antagonists or Direct Oral Anticoagulants in Atrial Fibrillation
by: Gencheva Dolina
Published: (2023-09-01)

Use of non-vitamin K antagonists oral anticoagulants in atrial fibrillation patients on dialysis
by: Wenhao Li, et al.
Published: (2022-09-01)

Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation
by: Surbhi Shah, et al.
Published: (2018-02-01)

Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin
by: Krishna N. Pundi, et al.
Published: (2021-12-01)

Anticoagulants for atrial fibrillation: from warfarin and DOACs to the promise of factor XI inhibitors
by: Vineet Kumar, et al.
Published: (2024-02-01)

Atrial Fibrillation and Stroke. A Review on the Use of Vitamin K Antagonists and Novel Oral Anticoagulants
by: Alfredo Caturano, et al.
Published: (2019-09-01)

Traditional warfarin (Coumadin) therapy usage experience on nonvalvular atrial fibrillation before non-Vitamin K antagonists (new oral anticoagulants) era from a center in Turkey
by: Emre Ozdemir, et al.
Published: (2020-01-01)

Efficacy and safety of non‐vitamin K antagonist oral anticoagulants versus warfarin in atrial fibrillation and kidney failure under hemodialysis: A meta‐analysis of controlled randomized trials
by: Ting‐Yung Chang, et al.
Published: (2025-06-01)

Changes in primary care management of atrial fibrillation patients following the shift from warfarin to non-vitamin K antagonist oral anticoagulants: a Norwegian population based study
by: Sigrun Halvorsen, et al.
Published: (2022-08-01)

Efficacy and safety outcomes of patients with atrial fibrillation compared between warfarin and non-vitamin K antagonist oral anticoagulants based on SAMe-TT2R2 score
by: Komsing Methavigul, et al.
Published: (2023-01-01)

Comparison of non-vitamin K antagonist oral anticoagulants and well-controlled warfarin in octogenarians with non-valvular atrial fibrillation: Real-world data from a single tertiary center
by: Arzu Neslihan Akgün, et al.
Published: (2021-07-01)

The influence of clinical and genetic factors on the stability of warfarin’s anticoagulant effect in patients with atrial fibrillation
by: Ya. M. Mykhailovskyi
Published: (2022-06-01)

Influencing Factors of Overanticoagulation at Initial Stage of Warfarin Anticoagulation Therapy in Patients with Atrial Fibrillation
by: FAN Caixia, LI Jiao, WEI Yanjin, GUO Dequn, LIU Cunfei, LI Zhengrong, QIU Shi
Published: (2024-01-01)

EFFECT OF ANTICOAGULANT TREATMENT OF DABIGATRAN AND WARFARIN ON HEMOSTASIS IN PATIENTS WITH LIVER CIRRHOSIS AND ATRIAL FIBRILATION.
by: A.E. Baylo, et al.
Published: (2022-02-01)

Direct comparison of non-vitamin K antagonist oral anticoagulant versus warfarin for stroke prevention in non-valvular atrial fibrillation: a systematic review and meta-analysis of real-world evidences
by: Yoga Waranugraha, et al.
Published: (2021-08-01)

Percutaneous Left Atrial Appendage Occlusion in Comparison to Non‐Vitamin K Antagonist Oral Anticoagulant Among Patients With Atrial Fibrillation
by: Peter A. Noseworthy, et al.
Published: (2022-10-01)

New anticoagulant drugs versus warfarin in atrial fibrillation: economic evaluation and cost-effectiveness analysis
by: Mauro Silingardi
Published: (2013-12-01)

Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation in secondary stroke and systemic embolism prevention
by: Iwona Gorczyca, et al.
Published: (2021-12-01)

Uptake of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation – a prospective cohort study
by: Matylda Zimny, et al.
Published: (2017-02-01)

The efficacy and safety of direct oral anticoagulants compared with vitamin K antagonist in patients with hypertrophic cardiomyopathy and atrial fibrillation
by: Si-qi Lyu, et al.
Published: (2024-01-01)

Perioperative interruption of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: A comparative analysis
by: Joseph R. Shaw, et al.
Published: (2020-01-01)

Safety and efficacy of low-dose non-vitamin K antagonist oral anticoagulants versus warfarin after left atrial appendage closure with the Watchman device
by: Guohua Fu, et al.
Published: (2022-08-01)

Comparison of Early Complications of Oral Anticoagulants after Totally Thoracoscopic Ablation: Warfarin versus Non-vitamin K Antagonist Oral Anticoagulants
by: MuHyung Heo, et al.
Published: (2023-03-01)

Comparison of Left Atrial Appendage Occlusion versus Non-Vitamin-K Antagonist Oral Anticoagulation in High-Risk Atrial Fibrillation: An Update
by: Shaojie Chen, et al.
Published: (2021-06-01)

Standard-Intensity Versus Low-Intensity Anticoagulation with Warfarin in Asian Patients with Atrial Fibrillation: A Multi-Center, Randomized Controlled Trial
by: Jeong Gwan Cho MD, PhD, et al.
Published: (2023-04-01)

Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation
by: Craig I. Coleman, et al.
Published: (2019-01-01)

Inadequate oral anticoagulation with warfarin in women with cerebrovascular event and history of atrial fibrillation: the FibStroke study
by: Aissa Bah, et al.
Published: (2021-01-01)

174 Peri-Procedural Warfarin Bridging Evaluation for Patients with Atrial Fibrillation Enrolled in an Anticoagulation Management Service
by: Hamza H. Sinan, et al.
Published: (2025-05-01)

Treatment Cost Analysis Study In Patients with Atrial Fibrillation Using Warfarin or New Generation Oral Anticoagulant
by: Altuğ Ösken, et al.
Published: (2021-06-01)

Prescribing and Safety of Direct-Acting Oral Anticoagulants Compared to Warfarin in Patients with Atrial Fibrillation on Chronic Hemodialysis
by: Estella Davis, et al.
Published: (2020-03-01)

Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK
by: Mar Martín-Pérez, et al.
Published: (2019-09-01)

Use of Direct‐Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Significant Tricuspid Regurgitation
by: Yujin Yang, et al.
Published: (2024-02-01)

Efficiency of the Left Atrial Appendage Thrombus Dissolution in Patients with Persistent Nonvalvular Atrial Fibrillation with Warfarin or Direct Oral Anticoagulants Therapy
by: E. S. Mazur, et al.
Published: (2021-11-01)